Leadership Team

The Leadership Team at Lyell Immunopharma is responsible for guiding the strategic direction and operational excellence of the company. Comprising key executives, including the Chief Financial Officer and Chief Medical Officer, the team collaborates to drive innovation in immuno-oncology, oversee clinical development, and ensure the alignment of business objectives with scientific advancements. Their collective expertise steers Lyell's mission to overcome challenges in T cell therapies and advance curative treatments for solid tumors.